130 related articles for article (PubMed ID: 3525449)
1. A phase II study of carboplatin in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study).
Arseneau J; Blessing JA; Stehman FB; McGehee R
Invest New Drugs; 1986; 4(2):187-91. PubMed ID: 3525449
[TBL] [Abstract][Full Text] [Related]
2. A phase II study of CHIP in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study).
McGuire WP; Blessing JA; Hatch K; DiSaia PJ
Invest New Drugs; 1986; 4(2):181-6. PubMed ID: 3733378
[TBL] [Abstract][Full Text] [Related]
3. A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study.
McGuire WP; Arseneau J; Blessing JA; DiSaia PJ; Hatch KD; Given FT; Teng NN; Creasman WT
J Clin Oncol; 1989 Oct; 7(10):1462-8. PubMed ID: 2674333
[TBL] [Abstract][Full Text] [Related]
4. Phase II evaluation of oxaliplatin in previously treated squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Fracasso PM; Blessing JA; Wolf J; Rocereto TF; Berek JS; Waggoner S
Gynecol Oncol; 2003 Jul; 90(1):177-80. PubMed ID: 12821360
[TBL] [Abstract][Full Text] [Related]
5. A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck.
Forastiere AA; Natale RB; Takasugi BJ; Goren MP; Vogel WC; Kudla-Hatch V
J Clin Oncol; 1987 Feb; 5(2):190-6. PubMed ID: 3543242
[TBL] [Abstract][Full Text] [Related]
6. A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: a Southwest Oncology Group study.
Weiss GR; Green S; Hannigan EV; Boutselis JG; Surwit EA; Wallace DL; Alberts DS
Gynecol Oncol; 1990 Dec; 39(3):332-6. PubMed ID: 2258080
[TBL] [Abstract][Full Text] [Related]
7. [Phase II study of carboplatin in cervical carcinoma].
Noda K; Kato T; Ikeda M; Akiya K; Yajima A; Ueda G; Nishiya I; Takamizawa H; Terashima Y; Tsutsui F
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3067-72. PubMed ID: 3056277
[TBL] [Abstract][Full Text] [Related]
8. Continuous infusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the cervix uteri IIB-IIIB (UICC). A phase I/II and pharmacokinetic study.
Micheletti E; La Face B; Bianchi E; Cagna E; Apostoli P; Ruggeri G; Verardi R; Sartori E
Am J Clin Oncol; 1997 Dec; 20(6):613-20. PubMed ID: 9391552
[TBL] [Abstract][Full Text] [Related]
9. Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.
Sutton GP; Blessing JA; Photopulos G; Berman ML; Homesley HD
Semin Oncol; 1989 Feb; 16(1 Suppl 3):68-72. PubMed ID: 2539647
[TBL] [Abstract][Full Text] [Related]
10. Echinomycin (NSC 526417) in recurrent and metastatic squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group (GOG).
Muss HB; Blessing JA; Eddy GL; McGehee R
Invest New Drugs; 1992 Apr; 10(1):25-6. PubMed ID: 1607251
[TBL] [Abstract][Full Text] [Related]
11. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Van Le L; Waggoner S
Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of carboplatin or iproplatin in cervical cancer.
Lira-Puerto V; Silva A; Morris M; Martinez R; Groshen S; Morales-Canfield F; Tenorio F; Muggia F
Cancer Chemother Pharmacol; 1991; 28(5):391-6. PubMed ID: 1914084
[TBL] [Abstract][Full Text] [Related]
13. Echinomycin (NSC 526417) in squamous-cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
Muss HB; Blessing JA; Malfetano J
Am J Clin Oncol; 1990 Jun; 13(3):191-3. PubMed ID: 2346124
[TBL] [Abstract][Full Text] [Related]
14. Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Rose PG; Blessing JA; Arseneau J
Gynecol Oncol; 1996 Jul; 62(1):100-2. PubMed ID: 8690279
[TBL] [Abstract][Full Text] [Related]
15. Carboplatin (NSC-241-240): an active platinum analog for the treatment of squamous-cell carcinoma of the head and neck.
Eisenberger M; Hornedo J; Silva H; Donehower R; Spaulding M; Van Echo D
J Clin Oncol; 1986 Oct; 4(10):1506-9. PubMed ID: 3531424
[TBL] [Abstract][Full Text] [Related]
16. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
Zamboglou N; Pape H; Schnabel T; Wurm R; Bannach B; Fürst G; Schmitt G
Strahlenther Onkol; 1989 Sep; 165(9):647-51. PubMed ID: 2678546
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
Mannel RS; Blessing JA; Boike G
Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of ifosfamide and mesna in patients with previously-treated carcinoma of the cervix. A Gynecologic Oncology Group study.
Sutton GP; Blessing JA; Adcock L; Webster KD; DeEulis T
Invest New Drugs; 1989 Nov; 7(4):341-3. PubMed ID: 2513286
[TBL] [Abstract][Full Text] [Related]
19. Phase I-II study of carboplatin vincristine methotrexate and bleomycin (COMB) in carcinoma of the cervix.
Rustin GJ; Newlands ES
Br J Cancer; 1988 Dec; 58(6):818-9. PubMed ID: 2465019
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy of advanced squamous carcinoma of the cervix: a phase I-II study of high-dose cisplatin and cyclophosphamide. A pilot study of the Gynecologic Oncology Group.
Jobson VW; Muss HB; Thigpen JT; Homesley HD; Bundy B
Am J Clin Oncol; 1984 Aug; 7(4):341-5. PubMed ID: 6540048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
